

LEMPO TEAM
Lempo employs a collaborative work model for its therapeutic programmes, working with clinicians and researchers at leading academic centres. Prof. Ben-Zion Garty, co-founder of Lempo and a renowned immunologist, explained, “Lempo works with carefully chosen research labs, led by worldwide experts in specific aspects of our program, covering CRISPR, HSCT, MPO deficiency, AAGN and PAH. Jointly, we are able to accelerate the program towards an optimal treatment”.
​
The operation is managed by a team of experienced professionals directing the distributed programmes. This model ensures high quality, fast pace and capital efficiency.
Leadership

Oren Glanz - CEO
20+ years as serial entrepreneur, and CEO, founded 8 companies and sold 2
​
Senior lecturer at the Israeli
Technion Institute
​
Recognized in 2012 as 1 of 100 most influential people in Israel

Anat Kahana, PhD - CSO
The inventor of Lempo MPO-001
​
Molecular Biologist – Tel Aviv
University, Bar-Ilan university and Weizmann institute of Science
​
Translational Medical Researcher

Prof. Ben-Zion Garty, MD
Clinical Research
MD Pediatric Immunology
Clinician - Allergies and
Immunodeficiency
​
Former head of children ward in Schneider Children Hospital
First physician in Israel to treat pediatric PAH
​
Full Professor at the Tel Aviv University medical school
Cooperating Labs



Prof. Donald B. Kohn, MD
Department of Microbiology, Immunology & Molecular Genetics University of California, Los Angele.
​
Broad Stem Cell Research Center, UCLA
​
Expertise: Gene Editing, Stem cells therapies, bone marrow transplant
​
Prof. Stephan Rosenkranz, MD
Head of the Pulmonary
Hypertension (PH) Center at the University of Cologne,
Germany, and Cologne
Cardiovascular
Research Center (CCRC)
​
Expertise: Pulmonary Arterial Hypertension, MPO in CVD
​
Prof. Daniel Offen, PhD
Head of Translational
Neuroscience Lab, Dept. of
Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience, Tel Aviv University.
​
Expertise:
Neurological diseases and
MPO
​
Scientific Advisory

Prof. William M. Nauseef,
MD
Inflammation program, Iowa
University Center for
Immunology and Immune-
based Diseases.
​
Expertise: MPO and MPO
Deficiency
​

Prof. David Jayne, MD, PhD
Clinical Autoimmunity, University of Cambridge
Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital.
Expertise: ANCA associated Vasculitis
​

Dr. Moshe Yeshurun, MD
Director of Bone Marrow Transplantation Department, Beilinson Hospital, Rabin Medical Center.
​
Expertise: Bone marrow and stem cell transplantation
​